| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |